For the past year, COVID-19 rattled the job market across Minnesota. Latinos, more than any other racial or ethnic group, remained in the state workforce. But many found themselves on divergent paths. Pandemic shutdowns cost restaurant owners and staff their livelihoods. Meanwhile, construction workers and contractors booked more jobs than they could handle.
Go Deeper.
Create an account or log in to save stories.
Like this?
Thanks for liking this story! We have added it to a list of your favorite stories.
If you've been feeling blah recently, you're not alone. The good news is you can retrain your brain to feel happier. Here's how to shift your mood and restore your well-being.
The state reported no deaths and 79 new cases, the third day with average daily cases remaining under 100. Minnesota is winding down its operations at six state-run COVID-19 testing sites as case counts decline.
Vaccines may not be as effective for those who are immuno-compromised. Protecting them needs to be made a top priority, says researchers — to keep them safe and to slow the emergence of variants.
Ringing in the ears has been on the rise during the pandemic. Here's what to know if you suffer from it, and techniques to help quiet the bothersome sound.
Vaccination rates are at a near standstill. Meanwhile, the most contagious variant of the COVID-19 virus yet is spreading quickly in the United States. Is another surge inevitable?
A college student never learned the cause of intense pain that drove her to an ER, but her bill totaled $18,735.93. She and her mom, a nurse practitioner, were outraged after dissecting the charges.
Have you toyed with ditching your job over the past year? Used the upheaval of the pandemic to make needed changes in your life and career? If so, you’re not alone.
The average number of new COVID-19 cases in Minnesota each day slipped below 100 over the weekend for the first time since the earliest weeks of the pandemic.
Doctors are trying to figure out who should get a new treatment for Alzheimer's disease which, at best, slows the fatal disease marginally. The drug's recent approval by the Food and Drug Administration has sparked both excitement and skepticism.